Treg inhibitor GIM-531
An orally bioavailable small molecule inhibitor of regulatory T-cells (Tregs), with potential immunomodulatory and antineoplastic activities. Upon oral administration, Treg inhibitor GIM-531 inhibits the activity of immune suppressive Tregs through an as of yet unknown mechanism of action. This may restore antitumor immune responses.
| Code name: | GIM 531 GIM-531 GIM531 |
|---|